POETIG Trial - POnatinib After rEsisTance to Imatinib in GIST

Clinical trial NCT03171389 · UNKNOWN

Trial details

NCT number: NCT03171389
Sponsor: Sebastian Bauer
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

GIST, Malignant KIT Exon 13 Mutation KIT Gene Mutation

Start date: 2017-03-22
Primary completion: 2018-09-22
Enrollment: 81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.